Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HIV hunters: new hospital teams aim to catch hidden cases across europe

NCT ID NCT06900829

Knowledge-focused Sponsor: Casper Rokx Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether setting up special HIV teams in hospitals can increase testing for undiagnosed HIV. The teams will remind doctors to test patients with certain health conditions, reduce stigma, and improve care links. Over 5,200 patients across ten European countries will be involved. The goal is to catch HIV earlier and improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HIV team implementation (behavioral intervention)
What this could lead to
If successful, this could show that dedicated HIV teams in hospitals help find undiagnosed HIV earlier, leading to better health outcomes and reduced spread.
What could go wrong
This is an implementation study, not a drug trial. Success depends on hospital staff cooperation and resources. Results may vary across countries and may not be easy to sustain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Since this study involves screening individuals presenting to a specific hospital through a hospital-wide intervention, the inclusion and exclusion criteria are established at the hospital level. Inclusion Criteria: 1. Standard of care: HIV testing for HIV indicator conditions should be part of routine care in the country, and any prevailing guidelines on HIV testing and prevention policies can be integrated. 2. Management approval: Hospital management must be willing to allocate resources and provide authorization for the proposed activities, including Surveillance, Audit \& Feedback, Education \& Training, Linkage to Prevention, and fostering an Enabling Environment, including stigma reduction. 3. Resources: Assembling an HIV team led by a local HIV expert should be viable considering the available human resources. 4. Data collection: There should be an IT specialist and IT infrastructure capable of flagging a pre-defined set of HIV indicator conditions and monitoring the project's implementation effects with feedback loops to healthcare professionals. 5. Quality assurance: Continuous linkage for care and access to antiretroviral therapy must be assured. 6. Ethics and Regulatory Compliance: Provision for ethical and regulatory compliance is necessary. Exclusion Criteria: Any hospital that does not meet the inclusion criteria will be excluded from participation. We will not use data of patients who have objected against the use of their data for research.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Education are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Education Electronic health records HIV HIV infection Prevention of infection with HIV-1 STIGMA

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    28 sites in 10 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Buckinghamshire Healthcare NHS Trust

    RECRUITING

    Aylesbury, HP21 8AL, United Kingdom

  • Central Military Emergency University Hospital "Dr. Carol Davila"

    RECRUITING

    Bucharest, 010825, Romania

  • Central city clinical hospital of Ivano-Frankivsk city council

    RECRUITING

    Ivano-Frankivsk, Ukraine

  • Charité Universitätsmedizin Berlin

    RECRUITING

    Berlin, 13353, Germany

  • Clinical Emergency Hospital "Prof. Dr. Agrippa Ionescu"

    RECRUITING

    Bucharest, 011356, Romania

  • Cologne University Hospital

    RECRUITING

    Cologne, 50937, Germany

  • European hospital of Marseille

    RECRUITING

    Marseille, 13003, France

  • Fundeni Clinical institute

    RECRUITING

    Bucharest, 022328, Romania

  • Haga Ziekenhuis

    RECRUITING

    The Hague, Netherlands

  • Hospital Universitario La Paz-Carlos III

    RECRUITING

    Madrid, 28029, Spain

  • Infanta Leonor

    RECRUITING

    Madrid, Spain

  • Klinikum der Technischen Universität München (TUM)

    RECRUITING

    München, 81675, Germany

  • L'Istituto Nazionale per le Malattie Infettive "L. Spallanzani" IRCCS

    RECRUITING

    Roma, 00149, Italy

  • La Princesa

    RECRUITING

    Madrid, Spain

  • Lviv National Medical University

    RECRUITING

    Lviv, 79010, Ukraine

  • National Institute for Infectious Diseases "Prof. Dr. Matei Bals"

    RECRUITING

    Bucharest, 021105, Romania

  • Ospedale San Raffaele S.r.l

    RECRUITING

    Milan, Italy

  • Państwowy Instytut Medyczny MSWiA w Warszawie

    RECRUITING

    Warsaw, 02-507, Poland

  • Rijnstate ziekenhuis

    RECRUITING

    Arnhem, Netherlands

  • Royal Free London

    RECRUITING

    London, NW3 2QG, United Kingdom

  • SPZZOZ Janów Lubelski

    RECRUITING

    Janów Lubelski, 23-300, Poland

  • Spitalul Universitar de Urgență București

    RECRUITING

    Bucharest, 050098, Romania

  • St. Joseph Krankenhaus Berlin Tempelhof

    RECRUITING

    Berlin, 12101, Germany

  • Stichting Catharina Ziekenhuis

    RECRUITING

    Eindhoven, 5623EJ, Netherlands

  • Stichting Maasstad Ziekenhuis

    RECRUITING

    Rotterdam, 3079DZ, Netherlands

  • University Hospital Ghent

    NOT_YET_RECRUITING

    Ghent, Belgium

  • University Medical Center Groningen

    RECRUITING

    Groningen, 9713GZ, Netherlands

  • Wojewodzki Szpital Zespolony

    RECRUITING

    Kielce, 25-736, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.